CollPlant Biotechnologies expands its reach beyond regenerative medicine, acquiring LightSolver to integrate photonic computing technology alongside its Q2 2026 financial report.
CollPlant reported Q2 2026 results and announced the LightSolver acquisition, expanding into photonic computing, which is likely to be viewed positively by investors.
LightSolver is the acquisition target, adding photonic computing capabilities to CollPlant's portfolio.
CollPlant Biotechnologies (CLGN) released its Q2 2026 financial results while simultaneously announcing the strategic acquisition of LightSolver. This move marks a significant pivot for the regenerative medicine firm as it integrates photonic computing capabilities into its existing technology portfolio.
The acquisition is designed to diversify CollPlant's technology portfolio by integrating LightSolver's photonic computing capabilities alongside the company's established work in regenerative medicine.